DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T.
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.
Br J Pharmacol 2009;
157 (02) 258-270
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.